Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,510.8
-4.5 (-0.18%)

 

  • STI Straits Times Index
    2,510.8
    -4.5 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,473.2
    15.8 (1.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    22,961.5
    -171.3 (-0.74%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,852.4
    6.1 (0.22%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,877.9
    -38.4 (-0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,753.6
    37.4 (0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,816.8M
  • Value: 4,142.6M
  • Rise: 214
  • Fall: 121
  • Unch: 473

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Mapletree Log Tr2.050+0.130
ComfortDelGro1.440-0.060
SPH1.280-0.180
Rex Intl0.155+0.015
Sembcorp Ind1.360-0.150
SATS2.660-0.160
Broadway Ind^0.116+0.018
Singtel2.490-0.020
CapitaMall Trust2.030+0.100
Oceanus^0.005-

World Indices

World Indices
Name Last Change
Nasdaq 9,489.9 +120.9
HSI 22,961.5 -171.3
HSCEI 9,561.0 +9.5
Jakarta 4,753.6 +37.4
Nikkei 225 21,877.9 -38.4
SSE Comp 2,852.4 +6.1
Shanghai A 2,989.9 +6.6
Shanghai B 200.2 -5.3
KOSPI 2,029.6 +1.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VTV THERAPEUTICS INC VTV THERAPEUTICS, INC. CLASS A
Updated on 29 May 2020 (End of trading day)
Last (USD): 2.880 Change: - High: 2.900 Remarks: -
Change (%): - Low: 2.740
Open 2.890 Yesterday's Close 2.88
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 165,355 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.26430 Trailing EPS (USD) e -0.24720 NAV (USD) b -0.9122
PE a - Trailing PE f - Price / NAV b -3.1572
Dividend (USD) d - Cash In Hand (USD) g 0.0429 Issued & Paid-up Shares c 44,680,200
Dividend Yield (%) d - Price / Cash In Hand g 67.133 Treasury Shares h -
Beta - 75 Daysi 0.561 R-Squared - 75 Days(%)i 8.44 Market Cap (M) 195.190
Beta - 500 Daysi 0.501 R-Squared - 500 Days (%)i 0.54 Enterprise Value (M) 249.819
Piotroski F Score 2 Exchange Code VTVT Par Value ( $ ) n.a.
52 Weeks Volatility (%) 90.58 Free Float (%) 19.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VTV THERAPEUTICS INC NASDAQ 195.190 - - -3.1572 -
Industry Biotechnology NASDAQ 2,804.765 373.358 68678.556 6.9644 0.682
Local Peer AMGEN INC NASDAQ 135,120.336 17.230 17.605 14.2457 2.539
Local Peer GILEAD SCIENCES INC NASDAQ 97,598.820 18.121 19.669 4.4228 3.269
Local Peer VERTEX PHARMACEUTICAL NASDAQ 74,661.405 63.444 49.414 11.5545 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 68,954.588 32.590 30.253 5.6832 -
Local Peer ILLUMINA INC NASDAQ 53,368.350 53.262 56.654 11.5142 -
Local Peer BIOGEN INC NASDAQ 50,113.096 8.510 8.524 3.9941 -
Local Peer SEATTLE GENETICS INC NASDAQ 27,213.365 - - 15.4129 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 26,477.157 11.012 11.153 2.2538 -
Local Peer MODERNA INC NASDAQ 22,830.276 - - 13.9134 -
Local Peer INCYTE CORPORATION NASDAQ 22,152.482 49.569 - 11.4322 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 19,268.182 - 169.010 5.9470 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 15,295.249 - - 11.3321 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), NOVAVAX INC (NASDAQ), ALKERMES PLC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), XENCOR INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), REGENXBIO INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), CYTOKINETICS INC (NASDAQ), COMPUGEN (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MACROGENICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), OMEROS CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), NANTKWEST INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ANAPTYSBIO INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MERUS B V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECIGEN INC (NASDAQ), PERSONALIS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KAMADA (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CHIASMA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), MEDICINOVA INC (NASDAQ), INFLARX N V (NASDAQ), XOMA CORP (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ORGENESIS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CABALETTA BIO INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), TREVENA INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SAVARA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SYNLOGIC INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), OTONOMY INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), VACCINEX INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INMUNE BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ADVAXIS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ZAFGEN INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), CURIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), EVOGENE LTD (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), OCUGEN INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PRECIPIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 125,417.415 46.747 43.295 14.5018 0.960
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,292.639 25.483 39.960 5.7241 0.743
Global Peer WUXI BIO HKEx 156,841.884 136.435 136.435 10.9675 -
Global Peer SINO BIOPHARM HKEx 152,789.896 49.780 73.400 - 0.656
Global Peer BEIGENE HKEx 97,646.990 - - 4.4798 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,377.197 80.316 64.276 4.0726 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 32,202.452 - - 10.7964 -
Global Peer 3SBIO HKEx 23,354.200 21.152 21.152 2.1691 -
Other Global Peers ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), ARCUS BIOSCIENCES INC (NYSE), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), KINTOR PHARMA-B (HKEx), AVITA MEDICAL LTD (ASX), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEE'S PHARM (HKEx), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), HOLISTA COLLTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), ANTEOTECH LIMITED (ASX), Suntar Eco-City^ (SGX), SIENNA CANCER DIAGNOSTICS LTD (ASX), BIONOMICS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-1.37 %
10 Days --0.100
-3.36 %
20 Days -+0.840
+41.18 %
Medium Term Return 3 Months --0.540
-15.79 %
6 Months -+1.390
+93.29 %
1 Year -+1.050
+57.38 %
Long Term Return 2 Years -+1.000
+53.19 %
3 Years --2.120
-42.40 %
Annualised Return Annualised --
-16.80 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.230 - 4.230 Change From 1 Year Low +1.650 % Change From 1 Year Low (%) +134.15
Change From 1 Year High -1.350 % Change From 1 Year High (%) -31.91
2 Years Range 0.683 - 6.090 Change From 2 Years Low +2.197 % Change From 2 Years Low (%) +321.42
Change From 2 Years High -3.210 % Change From 2 Years High (%) -52.71
5 Years Range 0.650 - 14.000 Change From 5 Years Low +2.230 % Change From 5 Years Low (%) +343.08
Change From 5 Years High -11.120 % Change From 5 Years High (%) -79.43
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

Historical Price Data

Date Open High Low Close Volume VWAP
29 May 2020 2.890 2.900 2.740 2.880 165,355 -
28 May 2020 2.890 2.925 2.820 2.880 163,677 -
27 May 2020 3.000 3.100 2.824 2.950 702,923 -
26 May 2020 3.030 3.030 2.530 2.870 628,971 -
22 May 2020 2.950 3.010 2.900 2.920 194,316 -
21 May 2020 3.000 3.190 2.900 2.920 489,605 -
20 May 2020 2.950 3.050 2.930 2.980 245,708 -
19 May 2020 2.990 3.050 2.880 2.950 255,337 -
18 May 2020 3.070 3.150 2.860 2.900 619,066 -
15 May 2020 3.050 3.088 2.900 2.980 285,197 -
14 May 2020 3.180 3.180 2.820 3.030 816,927 -
13 May 2020 2.660 3.310 2.660 3.190 2,698,201 -
12 May 2020 2.100 2.700 2.060 2.560 665,568 -
11 May 2020 2.030 2.170 2.030 2.090 160,178 -
08 May 2020 2.070 2.107 2.030 2.060 132,751 -
07 May 2020 2.110 2.130 2.010 2.130 129,598 -
06 May 2020 2.080 2.150 2.060 2.130 74,995 -
05 May 2020 2.080 2.140 2.050 2.090 64,931 -
04 May 2020 2.010 2.100 1.910 2.070 85,392 -
01 May 2020 2.070 2.080 1.870 2.040 132,771 -
30 Apr 2020 2.130 2.230 2.050 2.100 269,528 -
29 Apr 2020 2.140 2.250 2.090 2.120 130,575 -
Summary
Current 2 Weeks
(15 May 2020 to 29 May 2020)
3.050 3.190 2.530 2.880 3,750,155 -
Previous 2 Weeks
(01 May 2020 to 14 May 2020)
2.070 3.190 1.870 3.030 4,961,312 -
4 Weeks from
(02 Apr 2020 to 30 Apr 2020)
1.860 3.190 1.730 2.100 2,581,495 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.